- Home
- MEC vs INBX Comparison
MEC vs INBX Comparison
Compare MEC & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEC
- INBX
- Stock Information
- Founded
- MEC 1945
- INBX 2010
- Country
- MEC United States
- INBX United States
- Employees
- MEC N/A
- INBX N/A
- Industry
- MEC Industrial Specialties
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- MEC Industrials
- INBX Health Care
- Exchange
- MEC Nasdaq
- INBX Nasdaq
- Market Cap
- MEC 329.4M
- INBX 345.8M
- IPO Year
- MEC 2019
- INBX 2020
- Fundamental
- Price
- MEC $14.93
- INBX $27.12
- Analyst Decision
- MEC Strong Buy
- INBX Hold
- Analyst Count
- MEC 3
- INBX 2
- Target Price
- MEC $21.33
- INBX N/A
- AVG Volume (30 Days)
- MEC 99.4K
- INBX 113.1K
- Earning Date
- MEC 11-04-2025
- INBX 11-13-2025
- Dividend Yield
- MEC N/A
- INBX N/A
- EPS Growth
- MEC 64.18
- INBX N/A
- EPS
- MEC 0.86
- INBX N/A
- Revenue
- MEC $524,606,000.00
- INBX $1,400,000.00
- Revenue This Year
- MEC N/A
- INBX N/A
- Revenue Next Year
- MEC $17.38
- INBX N/A
- P/E Ratio
- MEC $16.60
- INBX N/A
- Revenue Growth
- MEC N/A
- INBX N/A
- 52 Week Low
- MEC $11.72
- INBX $10.81
- 52 Week High
- MEC $23.02
- INBX $30.23
- Technical
- Relative Strength Index (RSI)
- MEC 52.63
- INBX 56.13
- Support Level
- MEC $14.06
- INBX $27.51
- Resistance Level
- MEC $14.99
- INBX $28.86
- Average True Range (ATR)
- MEC 0.50
- INBX 1.49
- MACD
- MEC 0.07
- INBX -0.19
- Stochastic Oscillator
- MEC 58.61
- INBX 47.82
About MEC Mayville Engineering Company Inc.
Mayville Engineering Co Inc is involved in a manufacturing partner providing a full suite of manufacturing solutions from concept to production, including design, prototyping and tooling, fabrication, aluminum extrusion, coating, assembly and aftermarket components. Its customers operate in diverse end markets, including heavy- and medium-duty commercial vehicles, construction, power sports, agriculture, military, and other end markets. Its services comprise stamping, shearing, fiber laser cutting, forming, drilling, tapping, grinding, tube bending, machining, welding, assembly and logistic services.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.